SCHEMBL7712423

SCHEMBL7712423

COc1ccccc1Oc1cnc(N)nc1N1CCN(CCO)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.44
PDE4B Q07343 2/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
DRD2 P14416 5/20 0.42
HTR1A P08908 3/20 0.42
HTR7 P34969 3/20 0.42
HTR6 P50406 3/20 0.42
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 3/20 0.41
HTT P42858 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708454 0.89 ROCK2 (0.43) HTR2AROCK2ROCK1DRD2HTR1A
SCHEMBL7712404 0.87 METAP1 (0.44) ROCK2ROCK1DRD2HTR1AHTR7
SCHEMBL7714186 0.86 KMT2A (0.48) HTR2APDE4BROCK2ROCK1ALDH1A1
SCHEMBL7708539 0.84 MAPT (0.51) HTR2AROCK2ROCK1DRD2HTR1A
SCHEMBL7714281 0.83 HTR3E (0.44) HTR2AROCK2ROCK1DRD2HTR1A
SCHEMBL7714556 0.81 KMT2A (0.44) ROCK2ROCK1DRD2HTR1AHTR7
SCHEMBL7714141 0.81 SCN9A (0.47) HTR2AROCK2ROCK1DRD2HTR1A
SCHEMBL7713453 0.81 HTR3E (0.44) HTR2APDE4BROCK2ROCK1
SCHEMBL7714112 0.80 HTR3E (0.45) HTR2AROCK2ROCK1HTR6ALDH1A1
SCHEMBL7714564 0.80 HRH4 (0.43) HTR2AROCK2ROCK1DRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed